K&F Growth Acquisition Corp. II Class A Ordinary shares
K&F Growth Acquisition Corp. II focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2024 and is based in Manhattan Beach, California.
K&F Growth Acquisition Corp. II Class A Ordinary shares (KFII) - Total Liabilities
Latest total liabilities as of September 2025: $10.14 Million USD
Based on the latest financial reports, K&F Growth Acquisition Corp. II Class A Ordinary shares (KFII) has total liabilities worth $10.14 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
K&F Growth Acquisition Corp. II Class A Ordinary shares - Total Liabilities Trend (2024–2024)
This chart illustrates how K&F Growth Acquisition Corp. II Class A Ordinary shares's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
K&F Growth Acquisition Corp. II Class A Ordinary shares Competitors by Total Liabilities
The table below lists competitors of K&F Growth Acquisition Corp. II Class A Ordinary shares ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Foresee Pharmaceuticals Co Ltd
TWO:6576
|
Taiwan | NT$593.99 Million |
|
Jiangsu Boiln Plastics Co. Ltd.
SHE:301003
|
China | CN¥59.26 Million |
|
TaiMed Biologics
TWO:4147
|
Taiwan | NT$896.74 Million |
|
Cartesian Growth Corporation III Class A Ordinary Shares
NASDAQ:CGCT
|
USA | $13.54 Million |
|
Triveni Engineering & Industries Limited
NSE:TRIVENI
|
India | ₹15.63 Billion |
|
Ningbo MedicalSystem Biotechnology Co Ltd
SHE:300439
|
China | CN¥706.76 Million |
|
Dareway Software Co Ltd
SHG:688579
|
China | CN¥249.17 Million |
Liability Composition Analysis (2024–2024)
This chart breaks down K&F Growth Acquisition Corp. II Class A Ordinary shares's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 11.74 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.10 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.03 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how K&F Growth Acquisition Corp. II Class A Ordinary shares's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for K&F Growth Acquisition Corp. II Class A Ordinary shares (2024–2024)
The table below shows the annual total liabilities of K&F Growth Acquisition Corp. II Class A Ordinary shares from 2024 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $242.84K | -- |